AYTU BIOPHARMA, INC

AYTUNasdaq· Pharmaceutical Preparations

Price History

Revenue

$66.4M

▲ 1.8% YoY

Net Income

-$13.6M

▲ 14.4% YoY

EPS

$-2.16

▲ 24.5% YoY

Cash

$31.0M

▲ 54.7% YoY

FY 2025 · As of 2025-06-30

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.